07UB4KZ
Supplement Lymphatic, Mesenteric to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | U Supplement |
| Body Part | B Lymphatic, Mesenteric |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family covers procedures where a surgeon places biological or synthetic material onto or into a structure of the lymphatic and hemic system to reinforce it or bolster a function that has been weakened, most often after injury. The leading example is splenic salvage surgery: when the spleen has been lacerated in blunt abdominal trauma, wrapping it in absorbable mesh compresses the injured tissue and supports it while it heals, allowing the surgeon to avoid removing the organ altogether. Patients benefit because the spleen filters blood and helps fight certain bacteria, so keeping it intact lowers the lifetime risk of severe infection that follows a splenectomy.
The material itself is not doing the healing directly; it is holding tissue together and adding structural support so that the body's own repair processes can proceed without the organ falling apart or re-bleeding. Outside of splenic trauma, this family sees limited use elsewhere in the lymphatic system, since lymph nodes and channels are rarely reinforced with an implanted product.
Anatomy & Axis Detail
Lymphatic, Mesenteric
Mesenteric lymphatic tissue forms an extensive network of nodes and collecting vessels embedded in the mesentery that drains the small intestine and part of the colon, channeling chyle toward the cisterna chyli. Supplementation in this region typically addresses congenital lymphatic malformations, chylous leaks, or defects following extensive mesenteric resection, using grafted lymphatic tissue or a biologic patch to restore structural integrity and flow capacity. Because the mesenteric bed is richly vascularized and mobile, surgeons must avoid compromising bowel perfusion while placing supplemental material, and documentation should identify whether the procedure targets a localized segment or a broader mesenteric distribution to support correct root operation selection.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
A coder should look for documentation that a mesh, wrap, or similar reinforcing material was left in place around an existing structure, most commonly the spleen, distinguishing it from a laceration that was simply sutured closed. The operative note needs to specify both the material used and that it augments rather than replaces the organ. The most frequent error is defaulting to Repair whenever a splenic injury is fixed surgically, when the presence of a retained mesh wrap actually calls for Supplement with the correct device value recorded.